In rhabdomyosarcoma tumors without PAX3-FOXO1 gene fusions, FGFR4 mutations are found in 10% of cases, while nearly all tumors have elevated FGFR4 expression[8,41]. This evidence concerns the gene FGFR4 and rhabdomyosarcoma.